CDHA CAAR

January 29, 2018

CAAR – New England Journal of Medicine Article Abstract – January 29, 2018

Filed under: Reports and Articles — Tags: , , — admin @ 5:04 pm

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease,” by Lawrence S. Honig, Bruno Vellas, Michael Woodward, Mercè Boada, Roger Bullock, Michael Borrie, Klaus Hager, Niels Andreasen, Elio Scarpini, Hong Liu-Seifert, Michael Case, Robert A. Dean, Ann Hake, Karen Sundell, Vicki Poole Hoffmann, Christopher Carlson, Rashna Khanna, Mark Mintun, Ronald DeMattos, Katherine J. Selzler, and Eric Siemers (Vol. 378, No. 4, January 25, 2018, p. 321-330).

www.nejm.org/doi/full/10.1056/NEJMoa1705971?query=TOC

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress